# Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers

> **NCT00756743** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-04802540
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00756743
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756743, "Multiple Dose Safety Study of PF-04802540 in Healthy Volunteers". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00756743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*